Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1943

Bioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis Review

Bioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Bioniche Life Sciences, Inc. (Bioniche) is a research-based bio-pharmaceutical company. It undertakes the discovery, development, manufacture, and marketing of proprietary products and technologies for human and animal health markets globally. The company
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Bioniche Life Sciences, Inc. (Bioniche) is a research-based bio-pharmaceutical company. It undertakes the discovery, development, manufacture, and marketing of proprietary products and technologies for human and animal health markets globally. The company operates through three business units, namely, Human Health, Animal Health, and Food Safety. The Human Health division is involved development of discovery and clinical development of human health products focused on treatment of various types of cancers.

Bioniche Life Sciences, Inc. Key Recent Developments

Mar 07, 2013: Bioniche Life Sciences Reorganizes Its Human Health Business
Feb 06, 2013: Bioniche Life Sciences Reports Revenue Of CAD8.8m In Q2 Fiscal 2013
Nov 07, 2012: Bioniche Life Sciences Reports Revenue Of CAD6.7m In Q1 Fiscal 2013
Sep 12, 2012: Bioniche Life Sciences Reports Revenue Of CAD31.8m In Fiscal 2012
Jul 30, 2012: Bioniche Life Sciences Appoints James Rae As ChairmanGDPH4332FSA

This comprehensive SWOT profile of Bioniche Life Sciences, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Bioniche Life Sciences, Inc. - Key Facts 5
Bioniche Life Sciences, Inc. - Key Employees 6
Bioniche Life Sciences, Inc. - Key Employee Biographies 7
Bioniche Life Sciences, Inc. - Major Products and Services 8
Bioniche Life Sciences, Inc. - Pharmaceutical Pipeline Products Data 10
Bioniche Life Sciences, Inc., Pipeline Products by Therapy Area 10
Bioniche Life Sciences, Inc., Pipeline Products by Development Phase 11
Bioniche Life Sciences, Inc. - History 13
Bioniche Life Sciences, Inc. - Company Statement 17
Bioniche Life Sciences, Inc. - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Bioniche Life Sciences, Inc. - Key Manufacturing Facilities 21
Section 2 – Company Analysis 22
Bioniche Life Sciences, Inc. - Business Description 22
Bioniche Life Sciences, Inc. - Corporate Strategy 23
Bioniche Life Sciences, Inc. - SWOT Analysis 24
SWOT Analysis - Overview 24
Bioniche Life Sciences, Inc. - Strengths 24
Strength - Vertically Integrated Operations 24
Strength - Strong Patent Portfolio 24
Strength - In-house Research Expertise 24
Bioniche Life Sciences, Inc. - Weaknesses 24
Weakness - Concentrated Geographical Presence 24
Weakness - Revenue Concentration: Animal Health Division 25
Bioniche Life Sciences, Inc. - Opportunities 25
Opportunity - Strategic Business Initiatives 25
Opportunity - New Product Approvals and Launches 25
Opportunity - Market Potential: Cancer 26
Bioniche Life Sciences, Inc. - Threats 26
Threat - Stringent Government Regulations 26
Threat - Competitive Pressures 26
Threat - Increasing Counterfeit Products 26
Bioniche Life Sciences, Inc. - Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios - Capital Market Ratios 28
Financial Ratios - Annual Ratios 28
Performance Chart 30
Financial Performance 30
Financial Ratios - Interim Ratios 31
Financial Ratios - Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 33
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 34
Bioniche Life Sciences, Inc., Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Bioniche Life Sciences, Inc., Recent Developments 36
Mar 07, 2013: Bioniche Life Sciences Reorganizes Its Human Health Business 36
Feb 06, 2013: Bioniche Life Sciences Reports Revenue Of CAD8.8m In Q2 Fiscal 2013 36
Nov 07, 2012: Bioniche Life Sciences Reports Revenue Of CAD6.7m In Q1 Fiscal 2013 37
Sep 12, 2012: Bioniche Life Sciences Reports Revenue Of CAD31.8m In Fiscal 2012 39
Jul 30, 2012: Bioniche Life Sciences Appoints James Rae As Chairman 39
May 09, 2012: Bioniche Life Sciences Reports Revenue Of CAD8.7m In Q3 Fiscal 2012 39
Feb 08, 2012: Bioniche Life Sciences Reports Revenue Of CAD8.1m In Q2 Fiscal 2012 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Bioniche Life Sciences, Inc., Key Facts 5
Bioniche Life Sciences, Inc., Key Employees 6
Bioniche Life Sciences, Inc., Key Employee Biographies 7
Bioniche Life Sciences, Inc., Major Products and Services 8
Bioniche Life Sciences, Inc., Number of Pipeline Products by Therapy Area 10
Bioniche Life Sciences, Inc., Number of Pipeline Products by Development Stage 11
Bioniche Life Sciences, Inc., Pipeline Products By Therapy Area and Development Phase 12
Bioniche Life Sciences, Inc., History 13
Bioniche Life Sciences, Inc., Other Locations 19
Bioniche Life Sciences, Inc., Subsidiaries 20
Bioniche Life Sciences, Inc., Key Manufacturing Facilities 21
Bioniche Life Sciences, Inc., Key Competitors 27
Bioniche Life Sciences, Inc., Ratios based on current share price 28
Bioniche Life Sciences, Inc., Annual Ratios 28
Bioniche Life Sciences, Inc., Interim Ratios 31
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 33
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 34
Bioniche Life Sciences, Inc., Recent Deals Summary 35
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Bioniche Life Sciences, Inc., Pipeline Products by Therapy Area 10
Bioniche Life Sciences, Inc., Pipeline Products by Development Phase 11
Bioniche Life Sciences, Inc., Performance Chart (2008 - 2012) 30
Bioniche Life Sciences, Inc., Ratio Charts 32
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 33
Bioniche Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 34




...